C

Celldex Therapeutics

CLDX

37.560
USD
-0.54
(-1.42%)
مغلق
حجم التداول
23,266
الربح لكل سهم
0
العائد الربحي
0
P/E
-10
حجم السوق
1,907,757,013
أصول ذات صلة
A
AGEN
-0.05000
(-0.83%)
5.99000 USD
A
ATNM
-0.30000
(-4.33%)
6.63000 USD
C
CRVS
0.36000
(13.85%)
2.96000 USD
C
CVM
0.02000
(1.77%)
1.15000 USD
F
FATE
-0.46000
(-8.61%)
4.88000 USD
P
PIRS
0.480
(2.91%)
16.990 USD
الأخبار المقالات

العنوان: Celldex Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.